FDA Rebuffs Alimera Diabetes Eye Treatment Over Concerns
U.S. regulators have rejected Alimera Sciences Inc.'s eye implant treatment for diabetes patients, citing concerns about its safety as well as potential issues at the facility where the implant is manufactured,...To view the full article, register now.
Already a subscriber? Click here to view full article